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Continuous Countercurrent Tangential Chromatography (CCTC) for 
Purification of High Value Therapeutic Proteins 
Introduc*on	  
Continuous countercurrent tangential 
chromatography (CCTC) is a continuous, column-
free, and single-use process for protein purification 
- Stationary phase à flowing slurry 
- Fluid management à static mixers and hollow 
fiber membrane modules 
Binding, washing, elution, stripping, and 
regeneration performed directly on flowing slurry 
 
Demonstrate capability of using CCTC for 
continuous purification of mAb from clarified cell 
culture fluid 
Optimize performance of binding, washing, and 
elution steps using appropriate models for staged 
systems 
Explore potential for enhanced CCTC performance 
using small particle size resin 
6-­‐Step	  CCTC	  System	  for	  mAb	  Purifica*on	  
Materials	  and	  Methods	  
MidiCros® hollow fiber membranes – Spectrum Labs 
- 0.5 µm pore size, 1 mm inner diameter 
POROS MabCapture A resin – Life Technologies 
- 45 µm beads, Polystyrene matrix 
Clarified cell culture fluid - Regeneron 
- CHO cell culture, 6.9 g/L mAb 
Analytics 
- Soluble aggregates – SEC - UPLC 
- Host cell proteins / Leached Protein A – ELISA 
- Charge variants – HPLC CEX 
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(pressure) 





























CCTC – Continuous Performance 
Elution Step 
(mAb concentration) 





Host Cell Protein 180 ppm 600 ppm 
Soluble Aggregates 8.6 % 11 % 
Leached Protein A < 7 ppm < 7 ppm 
Variants (main peak) 53 % 50 % 
Productivity 55 g / L / h 20 g / L / h 
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Objec*ves	  
Conclusions 
CCTC provides truly continuous mAb purification with high yield 
(> 90%) and productivity (50 g/L/h or higher) 
Purity of mAb product is equal to or better than Protein A column 
- 3x lower HCP, similar leached Protein A and aggregates 
Significant opportunities for further improvements in performance 
- Small diameter beads, in-line mixing, enhanced staging 
ParticleDiameter
CCTC Enhancements 
Small Particle Resin 
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